Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MDVN $58.10 2.3300 +4.18%
GHDX $27.41 0.9400 +3.55%
PCYC $91.86 2.8700 +3.23%
ARRY $3.85 0.1100 +2.94%
NKTR $10.88 0.3000 +2.84%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

FATE $6.73 -0.9300 -12.14%
ONTY $2.35 -0.2300 -8.91%
AGIO $40.00 -3.9000 -8.88%
ARWR $11.42 -1.0700 -8.57%
RNN $0.93 -0.0783 -7.75%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

Supreme Court to Hear Appeal of Generic Drug Case

(New York Times) Mar 31, 2014 - The court’s decision could delay competitors’ generic versions of Copaxone, made by Teva Pharmaceutical Industries.
read article 

Sales Soar for Pricey Hepatitis Drug Sovaldi

(Wall Street Journal) Mar 31, 2014 - A hepatitis C pill from Gilead Sciences that costs $1,000 a day is on track to notch among the biggest sales ever for the first year of a newly approved drug, showing how hard it is for insurers to curb usage.
read article (paid subscription required) 

Leading Health Groups Urge President Obama to Release Proposal to Regulate Cigars, E-Cigarettes and Other Tobacco Products

(ACS CAN) Apr 1, 2014 - Six leading public health and medical organizations have asked President Obama to order the release of a critical public health proposal that would give the Food and Drug Administration (FDA) authority over all unregulated tobacco products.
read press release 

Giants of Cancer Care Nominations Deadline Extended to April 15

(Yahoo! Finance) Mar 31, 2014 - Esteemed oncology awards program to name giants in 16 distinct categories.
read article 

Association of Community Cancer Centers Honors Researcher and Community Oncologist with National Award

(ACCC) Mar 31, 2014 - John Powderly II, MD, and CPI (Certified Physician Investigator), president and founder of Carolina BioOncology Institute, Huntersville, N.C., is being honored with the Association of Community Cancer Centers (ACCC’s) 2014 David King Community Clinical Scientist Award.
read press release 

Association of Community Cancer Centers and Leukemia and Lymphoma Society to Honor Four Leading Oncology Professionals Active in Grassroots Advocacy

(ACCC) Mar 28, 2014 - The Association of Community Cancer Centers (ACCC), in conjunction with the Leukemia and Lymphoma Society (LLS), will be honoring four cancer care professionals for their dedicated and ongoing efforts to improve access to care in their states through grassroots advocacy efforts.
read press release 

She Was Studying Cancer’s Effects on People. Then She Got Lymphoma.

(Washington Post) Mar 31, 2014 - Last September, Abby Prestin received a CT scan that showed a large tumor pushing against her windpipe.
read article (free registration required) 

Opinion: How Big Pharma is Slowing Cancer Research

(Reuters/The Great Debate blog) Mar 31, 2014 - Drug patent issues are holding back some researchers.
read article 

Northwest Bio, DCVax and 'Compassionate Use'

(TheStreet) Mar 29, 2014 - Northwest Biotherapeutics takes umbrage at anyone who describes the German Hospital Exemption decision for its brain cancer vaccine DCVax as "compassionate use."
read article 

A Dose of Reality About Chemotherapy Dosing -- Saladax Has The Antidote - My5-FU™

(Saladax Biomedical) Mar 19, 2014 - Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is offering a simple blood test for the personalization and optimization of 5-fluorouracil (5-FU) dosing to help oncologists improve treatment outcomes and minimize the drug's toxic side effects.
read corporate press release 

FDA and Manufacturers Working to Ease Saline Shortage

(ASCO in Action) Apr 1, 2014 - Due to the shortage of normal saline, Fresenius Kabi USA LLC, announced that it will temporarily distribute normal saline in the U.S. from its Norway manufacturing facility.
read article 

OPKO Announces Launch of 4Kscore Test for Prostate Cancer

(MarketWatch) Mar 31, 2014 - OPKO Health, Inc. announced the availability of the 4KscoreTM Test through its CLIA-accredited OPKO Lab in Nashville, TN.
read article 

FORMA Therapeutics and Celgene Corporation Announce a Novel and Expansive Multi-Year Strategic Alliance

(Reuters) Apr 1, 2014 - Celgene expands FORMA’s discovery engine to deliver transformational medicines; FORMA controls projects through early clinical development and retains U.S. rights to all products; Celgene can gain an exclusive option to acquire FORMA.
read article 

McKesson Specialty Health to Acquire Majority Stake in Oncology Rehab Partners

(Yahoo! Finance) Apr 1, 2014 - McKesson Specialty Health, a division of McKesson Corporation focused on empowering specialty care providers, today announced an agreement to acquire a majority stake in Oncology Rehab Partners, an oncology rehabilitation services company based in Northboro, Mass.
read article 

NHS Cuts Putting Cancer Patients at Risk, Warn Doctors

(The Independent [UK]) Apr 1, 2014 - “Draconian” cuts to the NHS are putting cancer patients’ lives at risk, according to some of Britain’s leading doctors and surgeons.
read article 

Lawmakers Need to Address Crisis in Cancer Care Now

(Medscape Medical News) Apr 1, 2014 - Two community cancer care organizations have asked congressional leaders to pass Medicare reform legislation to stabilize the community cancer care delivery system.
read article (free registration required) 

AREVA Med Phase 1 Clinical Trial Expanded in U.S.

(Yahoo! Finance) Apr 1, 2014 - AREVA Med announced today the expansion of its Phase 1 clinical trial for patients with abdominal cancers through collaboration with UC San Diego.
read article 

From Dogs, Answers About Breast Cancer

(New York Times/Well blog) Mar 31, 2014 - Mammary tumors in strays can provide insights about breast cancer.
read article 

Digital Mammography Reduces Recall and Biopsy Rates

(RSNA) Apr 1, 2014 - Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer.
read press release 

Roswell Park Gets Green Light for Phase II Clinical Trial Using Interstitial Photodynamic Therapy to Treat Recurrent Head/Neck Cancers

(PRWeb) Apr 1, 2014 - A new phase II clinical trial will see Roswell Park investigators assessing the effectiveness of a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent head and neck tumors.
read press release 

Bad News, Good News for Colon Cancer Drug

(MedPage Today/The Gupta Guide) Mar 31, 2014 - Patients with advanced colorectal cancer lived longer with an epidermal growth factor receptor (EGFR) inhibitor than with an angiogenesis inhibitor, despite no improvement in progression-free survival (PFS), a randomized trial showed.
read article (free registration required) 

Some Colon Cancer Patients May Benefit From Aspirin

(WebMD/HealthDay News) Mar 31, 2014 - Recent research has raised the possibility that low-dose aspirin could add extra years to the lives of colon cancer patients. Now, a new study suggests that only certain patients may gain a survival benefit by taking aspirin after diagnosis.
read article 

Results From Phase III Patient Preference Study of GSK’s Votrient® (pazopanib) vs. Sutent® (sunitinib) in Advanced Renal Cell Carcinoma Published in Journal of Clinical Oncology

(GlaxoSmithKline) Apr 1, 2014 - Data from the first patient preference study in advanced renal cell carcinoma have been published in the Journal of Clinical Oncology.
read corporate press release 

New Urine Test Accurately Predicts Recurrence Of Bladder Cancer

(Forbes) Apr 1, 2014 - A DNA methylation marker test performed on urine samples obtained from patients with non-muscle-invasive bladder cancer (NMIBC) has the ability to predict tumor recurrence with both high sensitivity and specificity.
read article 

Judge Affirms Patent Protection for Eli Lilly’s Alimta

(Indianapolis Star) Apr 1, 2014 - A federal judge’s ruling gives Eli Lilly and Co. a critical win in a patent challenge to its new best-seller, the cancer drug Alimta.
read article